Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?
Ann Hematol
.
2010 Jan;89(1):105-6.
doi: 10.1007/s00277-009-0775-x.
Epub 2009 Jun 27.
Authors
Donat Dürr
,
Raffaele Daniele Siciliano
,
Yvonne Hummel
,
Alix O'Meara
,
Anita Hirschi
,
Roger Burkhard
,
Hanspeter Honegger
PMID:
19562341
DOI:
10.1007/s00277-009-0775-x
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Aged
Female
Follow-Up Studies
Gene Deletion*
Humans
Lenalidomide
Myelodysplastic Syndromes / drug therapy*
Myelodysplastic Syndromes / genetics*
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use
Substances
Thalidomide
Lenalidomide